COVID-19 Vaccine and Development of Immune Thrombocytopenic Purpura

This is a prospective, observational study conducted through Assiut University to investigate a potential relationship between the COVID-19 vaccine and the development of ITP. Participants aged 17-60 who received a COVID-19 vaccine at Assiut University Hospital (Egypt) between December 2021 to April 2023 are eligible to participate in the study. Those with previously diagnosed ITP, other causes of thrombocytopenia, or other autoimmune disorders will be excluded from the study.



back to top

Charity NavigatorGuideStar Seal NORD Member BadgeTHSNA logo